David R Guyer Selected Research

pegaptanib (Macugen)

4/2009	Pegaptanib sodium for macular edema secondary to central retinal vein occlusion.
2/2006	Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease.
1/2006	Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals.
10/2005	A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.
12/2004	Pegaptanib for neovascular age-related macular degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David R Guyer Research Topics

Disease

4	Macular Degeneration (Age-Related Maculopathy) 02/2006 - 02/2002
3	Choroidal Neovascularization 02/2012 - 02/2002
3	Macular Edema 04/2009 - 10/2005
1	Retinal Vein Occlusion 04/2009
1	Vascular Diseases (Vascular Disease) 02/2006
1	Diabetes Mellitus 01/2006
1	Retinal Neovascularization 01/2006
1	Endophthalmitis (Ophthalmia) 10/2005
1	Pain (Aches) 02/2002

Drug/Important Bio-Agent (IBA)

5	pegaptanib (Macugen)FDA Link 04/2009 - 12/2004
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2009 - 12/2004
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 02/2012
1	Biological ProductsIBA 02/2006
1	salicylhydroxamic acid (SHAM)IBA 01/2006
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2006
1	Niacin (Nicotinic Acid)FDA LinkGeneric 06/2003
1	Pharmaceutical PreparationsIBA 06/2003
1	Verteporfin (Visudyne)FDA Link 02/2002

Therapy/Procedure

3	Therapeutics 01/2006 - 02/2002
2	Injections 01/2006 - 10/2005
1	Light Coagulation 01/2006
1	Photochemotherapy (Photodynamic Therapy) 02/2002